LPSN · As filed with the SEC
Liveperson balance sheet, by quarter
The statement as Liveperson presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) · USD thousands
| USD thousands | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 |
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | 96,671 | 101,499 | 95,004 | 106,661 |
| Accounts receivable, net of allowances of $6,030 and $4,451 as of June 30, 2026 and December 31, 2025, respectively | 17,653 | 29,029 | 27,014 | 19,245 |
| Prepaid expenses and other current assets (Note 1) | 15,778 | 15,417 | 15,100 | 17,814 |
| Total current assets | 130,102 | 145,945 | 137,118 | 143,720 |
| Property and equipment, net (Note 6) | — | — | 90,389 | — |
| Property and equipment, net (Note 6) | 85,371 | 87,858 | — | 93,474 |
| Contract acquisition costs, net (Note 2) | 18,159 | 20,856 | 23,951 | 27,247 |
| Intangible assets, net (Note 5) | 13,421 | 13,502 | 13,409 | 15,516 |
| Goodwill, net (Note 5) | 132,386 | 184,540 | 184,902 | 226,516 |
| Deferred tax assets, net (Note 14) | 4,529 | 4,533 | 4,511 | 4,492 |
| Other assets | 318 | 348 | 387 | 484 |
| Total assets | 384,286 | 457,582 | 454,667 | 511,449 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||
| Current liabilities: | ||||
| Accounts payable | 9,542 | 4,357 | 9,522 | 6,551 |
| Accrued expenses and other current liabilities (Note 7) | 47,127 | 48,105 | 38,700 | 59,664 |
| Deferred revenue (Note 2) | 46,209 | 57,987 | 54,295 | 56,000 |
| Current portion of senior notes (Note 8) | 14,946 | 20,071 | 20,052 | — |
| Total current liabilities | 117,824 | 130,520 | 122,569 | 122,215 |
| Senior notes, net of current portion (Note 8) | 383,619 | 373,723 | 371,732 | 382,411 |
| Deferred tax liabilities | 4,202 | 4,199 | 4,196 | 3,782 |
| Other liabilities | 597 | 636 | 665 | 4,427 |
| Total liabilities | 506,242 | 509,078 | 499,162 | 512,835 |
| Preferred stock, $0.001 par value - 5,000,000 shares authorized, 26,551 and none issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | — | — | — | 20,664 |
| Preferred stock, $0.001 par value - 5,000,000 shares authorized; none issued and outstanding as of both December 31, 2025 and 2024 | — | — | 0 | — |
| Stockholders’ deficit: | ||||
| Common stock, $0.001 par value - 20,000,000 shares authorized, 12,520,490 and 12,223,729 shares issued, 12,336,086 and 12,039,325 shares outstanding as of June 30, 2026 and December 31, 2025, respectively. | 173 | 173 | 173 | 155 |
| Treasury stock - 184,404 shares at June 30, 2026 and December 31, 2025 | (3) | (3) | (3) | (3) |
| Additional paid-in capital | 1,025,853 | 1,023,338 | 1,021,076 | 997,483 |
| Accumulated deficit | (1,139,878) | (1,067,321) | (1,058,494) | (1,012,393) |
| Accumulated other comprehensive loss | (8,101) | (7,683) | (7,247) | (7,292) |
| Total stockholders’ deficit | (121,956) | (51,496) | (44,495) | (22,050) |
| Total liabilities and stockholders’ deficit | 384,286 | 457,582 | 454,667 | 511,449 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.